Emrg Mkts Index MSCI Ishares (EEM) News $EEM Indonesia

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Emrg Mkts Index MSCI Ishares (EEM) News $EEM

Indonesia ETFs Soaring on Political Hopes - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 9:00AM CDT
Indonesia ETFs are flying higher thanks to hopes of political candidate Joko Widodo taking power.

'Fast Money' Recap: Shaken by the Fed
at The Street - Thu Mar 20, 4:00AM CDT
The trading panel discussed the market reaction to the Fed's policy statement and which sectors will benefit most.

After Yesterday's Rally of 1.39% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Mar 18, 3:41PM CDT
iShares MSCI Emerging Markets Index Fund/United States (NYSE:EEM) traded in a range yesterday that spanned from a low of $38.93 to a high of $39.43. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $39.00 on volume of 68.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

iShares MSCI Emerging Markets Index Fund/United States Set to Possibly Pullback After Yesterday's Rally of 1.39%
Comtex SmarTrend(R) - Tue Mar 18, 3:41PM CDT
iShares MSCI Emerging Markets Index Fund/United States (NYSE:EEM) traded in a range yesterday that spanned from a low of $38.93 to a high of $39.43. Yesterday, the shares gained 1.4%, which took the trading range above the 3-day high of $39.00 on volume of 68.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

'Fast Money' Recap: Waiting on the Fed
at The Street - Tue Mar 18, 4:00AM CDT
The trading panel thinks the rally was no surprise, investors are skeptical and no one is selling aggressively ahead of the FOMC statement.

U.S. Investors Brace for Selling
at The Street - Mon Mar 17, 9:31AM CDT
As tension escalates in Russia and investors prepare for the Federal Reserve meeting Wednesday, safe haven assets may outperform U.S. equities.

'Fast Money' Recap: Market Volatility Returns
at The Street - Sat Mar 15, 4:00AM CDT
The trading panel discussed hedging, bond yields and China.

Don't Expect Copper to Bring Down U.S. Equities
at The Street - Fri Mar 14, 5:00AM CDT
As copper plummets, investors are becoming anxious. But Chinese economic weakness will not derail the U.S. equity rally.

After Yesterday's Decline of 1.12%, iShares MSCI Emerging Markets Index Fund/United States Offers Investors Better Value
Comtex SmarTrend(R) - Tue Mar 11, 3:41PM CDT
iShares MSCI Emerging Markets Index Fund/United States (NYSE:EEM) traded in a range yesterday that spanned from a low of $38.71 to a high of $39.43. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $38.92 on volume of 72.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iShares MSCI Emerging Markets Index Fund/United States Falls 1.12% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Mar 11, 3:41PM CDT
iShares MSCI Emerging Markets Index Fund/United States (NYSE:EEM) traded in a range yesterday that spanned from a low of $38.71 to a high of $39.43. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $38.92 on volume of 72.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Emerging Markets Can't Catch a Break
at The Street - Tue Mar 11, 1:46PM CDT
Emerging-market assets continue to fall as risks mount in China and Ukraine.

Vanguard Slashes Fees for 5 ETFs Including VWO - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Fri Mar 07, 9:00AM CST
Vanguard is looking to regain its title of cheapest ETF provider, cutting fees on several of its most popular funds.

Five Most Liquid ETFs of 2014 - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Thu Mar 06, 1:00PM CST
Looking for liquidity? Try these ETFs for returns.

April 25th Options Now Available For IShares MSCI Emerging Markets Index Fund (EEM)
at The Street - Thu Mar 06, 10:00AM CST
Investors in iShares MSCI Emerging Markets Index Fund saw new options begin trading today, for the April 25th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the EEM options chain for the new April 25th contracts...

iShares Plans New Type of Emerging Market ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Mar 06, 7:02AM CST
iShares is looking to launch a new form of emerging market ETF with a developed market twist.

'Fast Money' Recap: Mardi Gras on Wall Street
at The Street - Wed Mar 05, 4:00AM CST
The trading panel discussed Tuesday's rebound after Monday's drop and how investors can trade on the world's troubles.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 34

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 44

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 41

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 39

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 31

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

KPN Achieves Impressive Growth; Forecast for 2025 Enhanced

Updated Category News Views 271

KPN Achieves Remarkable Growth in Q2 2025 KPN has recently demonstrated a strong performance in the second quarter of 2025, showcasing impressive growth across various segments. The company reported a year-on-year growth of 3.7% in service revenues, a testament to its robust business strategy and market position. Consumer Service Revenue Gains The consumer segment has...

Continue Reading
Socket Mobile's Financial Trends Show Promise for Future Growth

Updated Category News Views 66

Socket Mobile Reports Q3 Financial Results Socket Mobile, Inc. (NASDAQ: SCKT), a prominent name in the field of data capture and delivery solutions, recently disclosed its financial results for the third quarter of 2024, presenting notable shifts in revenue and product adoption. The company emphasizes its commitment to enhancing productivity through innovative...

Continue Reading
Sapiens Recognized for Outstanding Software Solutions Excellence

Updated Category News Views 220

Sapiens UnderwritingPro Achieves Recognition for Excellence Sapiens International Corporation has once again made waves in the insurance industry with its advanced UnderwritingPro solution. Renowned for driving efficiency and automation, the software provides comprehensive functionality that benefits insurers across various sectors. Honored with the XCelent Award...

Continue Reading
Opportunity for LAZR Investors: Join the Class Action Today

Updated Category News Views 175

Investing in Luminar Technologies: What You Need to Know For those invested in Luminar Technologies, Inc. (NASDAQ: LAZR), important news is unfolding regarding a recent class-action lawsuit that has potential implications for shareholders. The Rosen Law Firm, a reputable entity in securities law, has issued a reminder for investors who purchased Luminar securities during...

Continue Reading
Celebrating HVAC Techs: Behind-the-Scenes Heroes

Updated Category News Views 8

Recognizing the Unsung Heroes of Home Comfort Let's face it, HVAC techs don't always get the recognition they deserve. On National HVAC Technician Day, June 22, Bacon Plumbing Heating Air Electric took a moment to shine a light on those skilled folks keeping homes comfy year-round across the Dallas-Fort Worth Metroplex. You know, the folks who swoop in just in time during...

Continue Reading